Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Clinical trial NCT00617799 · COMPLETED
Trial details
- NCT number
- NCT00617799
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-10-02
- Primary completion
- 2009-02-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.